May Hill Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
36,875
+216
+0.6% +$11.7K 0.33% 58
2026
Q1
$2.3M Buy
36,659
+371
+1% +$29.7K 0.58% 35
2025
Q4
$3.46M Sell
36,288
-145
-0.4% -$14.2K 0.93% 21
2025
Q3
$3.56M Sell
36,433
-24,240
-40% -$2.51M 1.04% 21
2025
Q2
$6.52M Buy
60,673
+52
+0.1% +$5.26K 2.15% 9
2025
Q1
$6.12M Sell
60,621
-68
-0.1% -$6.85K 2.31% 9
2024
Q4
$5.42M Buy
+60,689
New +$5.34M 2.1% 9

Other funds holding BSX

May Hill Capital's BSX Position: Q2 2026 in Review

May Hill Capital increased its Boston Scientific (BSX) stake by 0.59% in Q2 2026, buying an estimated $11.7K and bringing the position to 36,875 shares worth $1.57M. The position accounts for 0.33% of the portfolio, ranked #58.

May Hill Capital first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.52M in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • May Hill Capital held 36,875 shares of Boston Scientific worth $1.57M as of Q2 2026.
  • May Hill Capital bought 216 Boston Scientific shares in Q2 2026, an estimated $11.7K.
  • Boston Scientific made up 0.33% of May Hill Capital's portfolio in Q2 2026, its #58 holding.
  • May Hill Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • May Hill Capital's Boston Scientific position peaked at $6.52M in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.